Trial NCT04656691

View at ClinicalTrials.gov 
Org. Study IDs: 2020-0081_

Last trial update was posted on 2022-03-18

MeSH Interventions

Bamlanivimab

MeSH Conditions

COVID-19

Other Conditions

Covid19

Stopping Reasons

In April 2021 FDA revoked the Emergency Use Authorization after determining that the known and potential benefits of bamlanivimab, when administered alone, no longer outweigh the known and potential risks for its authorized use.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID